High-quality steel: A prerequisite for safer surgical procedures
The margin for error in surgical procedures is extremely narrow, especially as clinical techniques become more advanced and minimally invasive. …
Post
-
-
Thermo Fisher agrees to sell microbiology business to Astorg in $1bn deal
Thermo Fisher has agreed to sell its microbiology business in a deal above $1bn to private equity firm Astorg, reflecting …
-
Merck KGaA and Remepy join forces to develop combo drug-digital therapies
Merck KGaA has inked a collaboration deal with Israeli-US startup, Remepy, to explore the therapeutic potential of combination drug and …
-
iRhythm demonstrates value in 14-day monitoring for arrhythmia recurrence
New data from iRhythm Technologies has demonstrated that extending the cardiac monitoring duration for arrhythmia recurrence to 14 days resulted …
-
Tandem secures FDA approval for Control-IQ+ use in pregnancy
Tandem Diabetes Care has received approval from the US Food and Drug Administration (FDA) for its Control-IQ+ automated insulin delivery …
-
Nervonik closes $52.5m Series B funding to advance PNS system
US-based medical device company Nervonik has secured $52.5m in Series B financing aimed at advancing its peripheral nerve stimulation (PNS) …
-
HRS 2026: Medtronic, Boston Scientific and Abbott debut key PFA data
Boston Scientific, Abbott and Medtronic all presented successful readouts of their cardiac devices during the Heart Rhythm Society’s (HRS) 2026 …
-
Motif Neurotech secures FDA IDE to initiate depression implant study
The US Food and Drug Administration (FDA) has granted Motif Neurotech an investigational device exemption (IDE) to initiate a study …
-
J&J agrees to acquire Atraverse Medical to advance cardiac ablation portfolio
Johnson & Johnson (J&J) has agreed to acquire Atraverse Medical in a development that will give the medtech giant a …
-
Adagio Medical reports positive six-month results in FULCRUM-VT trial
Adagio Medical has reported positive six-month data from its pivotal FULCRUM-VT trial, supporting its plans to seek premarket approval from …
-
BrioHealth secures FDA approval to launch BrioVAD system trial
BrioHealth Solutions has secured conditional approval from the US Food and Drug Administration (FDA) to initiate a clinical trial of …
-
Edwards Lifesciences raises FY26 guidance following strong Q1
Edwards Lifesciences has lifted its full-year 2026 growth outlook to between 9% and 11%, up from 8% to 10% previously, due …
-
Imricor begins US commercial sales of NorthStar mapping system
Imricor Medical Systems has started commercial distribution of its NorthStar mapping system in the US. According to the company, the technology …
-
FDA and CMS outline new Medicare coverage pathway for medical device access
The US Centers for Medicare & Medicaid Services (CMS) and the US Food and Drug Administration (FDA) have introduced a …
-
First patient dosed in GE HealthCare’s Phase II/III LUMINA clinical trial
GE HealthCare has dosed the first patient in its international, multi-centre Phase II/III LUMINA clinical trial for the investigational manganese-based …
